Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Bio-Techne Corporation

Market Cap 8.79B 7.58B 6.98B 6.54B 12.29B 831B 12.42B 82.47B 32.22B 407B 33B 32.3B 1,408B P/E Ratio 2026 *
48.2x
P/E Ratio 2027 * 40.6x
Enterprise Value 8.72B 7.52B 6.92B 6.49B 12.2B 825B 12.32B 81.81B 31.96B 404B 32.74B 32.05B 1,397B EV / Sales 2026 *
7.22x
EV / Sales 2027 * 6.67x
Free-Float
99.7%
Yield 2026 *
0.57%
Yield 2027 * 0.57%
1 day-0.65%
1 week+2.36%
Current month+7.77%
1 month+25.35%
3 months+14.11%
6 months-3.04%
Current year-5.30%
1 week 51.96
Extreme 51.965
56.96
1 month 43.2
Extreme 43.2
56.96
Current year 43.2
Extreme 43.195
72.16
1 year 43.2
Extreme 43.195
72.16
3 years 43.2
Extreme 43.195
89.91
5 years 43.2
Extreme 43.195
135.96
10 years 23.92
Extreme 23.92
135.96
Manager TitleAgeSince
Chief Executive Officer 59 2024-01-31
Director of Finance/CFO 55 2014-03-31
Chief Tech/Sci/R&D Officer - 2023-08-05
Director TitleAgeSince
Chairman 70 2012-11-01
Director/Board Member 56 2009-05-18
Director/Board Member 63 2017-10-25
Date Insider Type Main position Quantity % Market Cap.
06-01Fiscal year

Executive/Senior Manager

1,416 0.0009%
05-07Other

Director

19,908 0.0127%
05-04Fiscal year

Chief Financial Officer

180,955 0.1157%
Change 5-day change 1-year change 3-year change Capi.($)
-0.50%+2.36%+7.87%-29.04% 8.79B
-0.13%+0.12%-12.54%-12.63% 43.58B
-3.01%+3.88%+290.65%+531.03% 34.03B
+0.02%-4.51%+11.68%-17.67% 29.77B
-0.61%-0.70%+0.71%+33.01% 29.82B
-0.29%+9.47%+13.95%+21.93% 25.42B
+2.36%+6.97% - - 13.87B
-1.54%-1.63%+52.56%+107.00% 13.35B
-1.20%-3.63%+2.25%+1.82% 12.85B
-1.73%-2.67%+105.99%+76.96% 12.22B
Average -0.69%+2.49%+52.57%+79.16% 22.37B
Weighted average by Cap. -0.73%+2.20%+57.96%+98.51%

Financials

2026 *2027 *
Net sales 1.21B 1.04B 959M 900M 1.69B 114B 1.71B 11.34B 4.43B 55.95B 4.54B 4.44B 194B 1.27B 1.09B 1B 942M 1.77B 120B 1.79B 11.87B 4.64B 58.57B 4.75B 4.65B 203B
Net income 184M 159M 146M 137M 258M 17.43B 260M 1.73B 675M 8.53B 692M 677M 29.53B 220M 190M 175M 164M 308M 20.81B 311M 2.06B 807M 10.19B 826M 809M 35.26B
Net Debt -70.15M -60.47M -55.65M -52.21M -98.06M -6.63B -99.04M -658M -257M -3.25B -263M -258M -11.24B -358M -309M -284M -267M -501M -33.85B -506M -3.36B -1.31B -16.58B -1.34B -1.32B -57.36B
Logo Bio-Techne Corporation
Bio-Techne Corporation specializes in the manufacture and marketing of products used in life science research. The group offers reagents and diagnostic tools for researchers, doctors, laboratories, pharmaceutical and biotechnology companies, etc. Net sales break down by family of products as follows: - biological and chemical reagents and analysis tools (71.3%): proteins, antibodies, molecules, culture serums, tools for cell work, tools for the study of proteins, immunoassay tools, etc.; - diagnostic and genomics products (28.4%): reagents and products used in blood analysis, nucleic acid analysis, tissue biopsy, gene analysis, cancer and genetic carrier screening, etc. ; - other (0.3%). Net sales are distributed geographically as follows: the United States (56%), the United Kingdom (4.5%), Europe/Middle East/Africa (21.8%), China (8.3%), Asia/Pacific (6.3%) and other (3.1%).
Employees
3,100
Date Price Change Volume
26-06-16 55.62 $ -0.98% 180,647
26-06-15 56.17 $ +4.02% 3,298,763
26-06-12 54.00 $ -0.04% 2,558,198
26-06-11 54.02 $ +2.90% 2,664,482
26-06-10 52.50 $ -3.51% 2,648,764
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
56.17USD
Average target price
61.69USD
Spread / Average Target
+9.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TECH Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!